Galectin Therapeutics Inc (GALT)
NASDAQ:GALT
Holding GALT?
Track your performance easily

Galectin Therapeutics (GALT) Income Statement

561 Followers

Galectin Therapeutics Income Statement

Last quarter (Q2 2024), Galectin Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Galectin Therapeutics's net income was $-12.44M. See Galectin Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
------
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 39.67M$ 38.07M$ 38.35M$ 30.18M$ 23.44M$ 13.44M
Operating Income
$ -39.67M$ -38.07M$ -38.35M$ -30.18M$ -23.44M$ -13.44M
Net Non Operating Interest Income Expense
$ -2.44M$ -2.56M$ -981.00K$ -486.00K$ -21.00K$ 144.00K
Other Income Expense
$ 608.00K$ -432.00K$ 557.00K$ -138.00K--
Pretax Income
$ -43.02M$ -41.07M$ -38.78M$ -30.53M$ -23.46M$ -13.29M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -48.03M$ -44.80M$ -38.87M$ -30.70M$ -23.60M$ -20.18M
Basic EPS
$ -0.79$ -0.74$ -0.65$ -0.52$ -0.41-
Diluted EPS
$ -0.79$ -0.74$ -0.65$ -0.52$ -0.41$ -0.39
Basic Average Shares
$ 245.78M$ 60.16M$ 59.39M$ 58.53M$ 57.03M$ 52.24M
Diluted Average Shares
$ 245.78M$ 60.16M$ 59.39M$ 58.53M$ 57.03M$ 52.24M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 39.67M$ 38.07M$ 38.35M$ 30.18M$ 23.44M$ 13.44M
Net Income From Continuing And Discontinued Operation
$ -44.28M$ -41.07M$ -38.78M$ -30.53M$ -23.46M$ -13.29M
Normalized Income
$ -38.50M$ -32.44M-$ -24.12M--
Interest Expense
------
EBIT
$ -41.55M$ -38.27M$ -37.74M$ -30.04M$ -23.38M$ -13.21M
EBITDA
$ -41.52M$ -38.24M$ -37.71M$ -30.00M$ -23.34M$ -13.17M
Currency in USD

Galectin Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis